UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016644
Receipt number R000019312
Scientific Title Non-inferiority trial of cardiovascular dynamics of lidocaine with adrenaline injection under general anesthesia between antipsychotics patients and control patients
Date of disclosure of the study information 2015/04/01
Last modified on 2022/03/03 10:03:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Non-inferiority trial of cardiovascular dynamics of lidocaine with adrenaline injection under general anesthesia between antipsychotics patients and control patients

Acronym

Cardiovascular dynamics of lidocaine with adrenaline injection to antipsychotics patients

Scientific Title

Non-inferiority trial of cardiovascular dynamics of lidocaine with adrenaline injection under general anesthesia between antipsychotics patients and control patients

Scientific Title:Acronym

Cardiovascular dynamics of lidocaine with adrenaline injection to antipsychotics patients

Region

Japan


Condition

Condition

patients taking antipsychotics

Classification by specialty

Psychiatry Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This non-inferiority trial is comparison of cardiovascular dynamics between antipsychotics patients and control patients under general anesthesia.
These patients are measured of vital sign after lidocaine with adrenaline injection

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1)Incidence of blood pressure decrease over 31 mmHg until 10 minutes after injection
2)Adverse event until 24 hours after injection

Key secondary outcomes

Abnormity of vital sign after injection


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

1)No premedication
2)Patients administer GA by TIVA (air, oxygen, propofol and remifentanil)
3)Take base line measurements if vital sign stable
4)One point eight ml lidocaine with adrenaline injection to oral mucosa during 30 seconds
5)Measurement of blood pressure at 0,4,10 minutes after injection
6)Give pressor drugs when systolic pressure under 70 mmHg, and time drug name and dose be recorded
7)Dental procedure start after ten minutes
8)Measurement of blood pressure, heart rate and SpO2 every 5 minutes after injection

Interventions/Control_2

1)No premedication
2)Patients administer GA by TIVA (air, oxygen, propofol and remifentanil)
3)Take base line measurements if vital sign stable
4)One point eight ml lidocaine with adrenaline injection to oral mucosa during 30 seconds
5)Measurement of blood pressure at 0,4,10 minutes after injection
6)Give pressor drugs when systolic pressure under 70 mmHg, and time drug name and dose be recorded
7)Dental procedure start after ten minutes
8)Measurement of blood pressure, heart rate and SpO2 every 5 minutes after injection

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

dental patients under general anesthesia and dental patients he or she taking antipsychotics under general anesthesia

Key exclusion criteria

1)ASA over 3
2)Taking circulation drugs
3)Taking tricyclic antidepressants
4)History of local anesthetics allergy
5)History of Hypertension, Arteriosclerosis, heart failure, hyperthyroidism, diabetes

Target sample size

720


Research contact person

Name of lead principal investigator

1st name katsuhisa
Middle name
Last name sunada

Organization

Nippon Dental University

Division name

dental anesthesiology

Zip code

102-8157

Address

Fujimi

TEL

03-3261-6064

Email

katsu.sunada@nifty.com


Public contact

Name of contact person

1st name katsuhisa
Middle name
Last name sunada

Organization

Nippon Dental University

Division name

dental anesthesiology

Zip code

102-8157

Address

Fujimi

TEL

03-3261-6064

Homepage URL


Email

katsu.sunada@nifty.com


Sponsor or person

Institute

the japanese dental society of anesthesiology

Institute

Department

Personal name



Funding Source

Organization

japanese association for dental science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of JDSA

Address

1-43-9 Komagome Toshima Tokyo Japan

Tel

03-3947-8891

Email

gakkai12@kokuhoken.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本歯科大学生命歯学部、昭和大学歯学部、東京歯科大学、東京医科歯科大学歯学部(以上東京都)、神戸市立医療センター西市民病院(兵庫県)、徳島大学歯学部(徳島県)、岩手医科大学歯学部(岩手県)、鹿児島大学歯学部(鹿児島県)、福岡歯科大学(福岡県)、大阪大学歯学部(大阪府)、日本歯科大学新潟生命歯学部(新潟県)、神奈川歯科大学(神奈川県)、岡山大学歯学部(岡山県)


Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 01 Day


Related information

URL releasing protocol

https://meridian.allenpress.com/anesthesia-progress/article/68/3/141/471169/Hemodynamic-Impact-of-Dr

Publication of results

Published


Result

URL related to results and publications

https://meridian.allenpress.com/anesthesia-progress/article/68/3/141/471169/Hemodynamic-Impact-of-Dr

Number of participants that the trial has enrolled

30

Results

No statistically significant changes were observed in the SBP, DBP, HR, or SpO2 for the 10 minute period after the administration of epinephrine
containing lidocaine. No abnormalities in the
hemodynamic parameters were noted over the 1 hour period following the local anesthetic
injection.

Results date posted

2022 Year 03 Month 03 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Regularly used typical and/or atypical
antipsychotics for more than 3 months and were
scheduled for restorative dental procedures and/or extractions under general anesthesia at
Nippon Dental University Hospital.

Participant flow

Informed consent was obtained from all
individual participants or legal guardians
included in the study.

Adverse events

None

Outcome measures

systolic blood pressure, diastolic blood pressure, heart rate, oxygen saturation

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2015 Year 03 Month 31 Day

Date of IRB

2015 Year 03 Month 30 Day

Anticipated trial start date

2015 Year 04 Month 01 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry

2016 Year 03 Month 31 Day

Date trial data considered complete

2016 Year 03 Month 31 Day

Date analysis concluded

2016 Year 04 Month 30 Day


Other

Other related information



Management information

Registered date

2015 Year 02 Month 26 Day

Last modified on

2022 Year 03 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019312


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name